系列表观扩散系数评估低级别胶质瘤患者的肿瘤进展
本回顾性研究纳入69例低级别胶质瘤患者中的28例,由两名神经放射科医生独立阅片,依据RANO标准判定肿瘤进展,比较稳定与进展患者的ADC均值及第10百分位ADC(ADC10)。ADC10的间期变化与最终病灶转归的一致性高于单时间点ADC值,诊断准确率86%(P<.001),平均提前8个月预测进展。
要点
- ADC10的间期变化与肿瘤进展的一致性高于单时间点ADC值。
- ADC10间期变化在13例进展患者中12例符合预期模式,总诊断准确率86%(P<.001)。
- ADC10间期变化平均比常规MR出现明显影像学进展提前8个月预测进展。
核心结论
- ADC10值的间期变化可用于识别低级别胶质瘤的进展与稳定,诊断准确率86%,并可在常规MR出现明显影像学进展之前发现进展。
研究设计与样本
- 回顾性研究,纳入至少12个月影像随访的低级别胶质瘤患者,69例中28例符合纳入标准;两名神经放射科医生独立阅片,依据RANO标准判定肿瘤进展,计算FLAIR高信号肿瘤体积的归一化平均ADC(ADCmean)和第10百分位ADC(ADC10)。
诊断标准与关键数值
- ADC10间期变化区分稳定与进展的诊断准确率86%,P<.001;13例进展患者中12例ADC10间期变化符合预期模式。
临床应用与阅片要点
- 连续随访中关注ADC10值的间期变化,其与最终病灶转归的一致性高于单时间点ADC值,并可能早于常规MR显示的进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Early and accurate identification of tumor progression in patients with low-grade gliomas is challenging. We aimed to assess the role of quantitative ADC analysis in the sequential follow-up of patients with low-grade gliomas as a potential imaging marker of tumor stability or progression.
MATERIALS AND METHODS: In this retrospective study, patients with a diagnosis of low-grade glioma with at least 12 months of imaging follow-up were retrospectively reviewed. Two neuroradiologists independently reviewed sequential MR imaging in each patient to determine tumor progression using the Response Assessment in Neuro-Oncology criteria. Normalized mean ADC (ADCmean) and 10th percentile ADC (ADC10) values from FLAIR hyperintense tumor volume were calculated for each MR image and compared between patients with stable disease versus tumor progression using univariate analysis. The interval change of ADC values between sequential scans was used to differentiate stable disease from progression using the Fisher exact test.
RESULTS: Twenty-eight of 69 patients who were evaluated met our inclusion criteria. Fifteen patients were classified as stable versus 13 patients as having progression based on consensus reads of MRIs and the Response Assessment in Neuro-Oncology criteria. The interval change of ADC values showed greater concordance with ultimate lesion disposition than quantitative ADC values at a single time point. The interval change in ADC10 matched the expected pattern in 12/13 patients with tumor progression (overall diagnostic accuracy of 86%, P <.001). On average, the ADC10 interval change predicted progression 8 months before conventional MR imaging.
CONCLUSIONS: The interval change of ADC10 values can be used to identify progression versus stability of low-grade gliomas with a diagnostic accuracy of 86% and before apparent radiologic progression on conventional MR imaging.
引用
- Chen IE, Swinburne N, Tsankova NM, et al. Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma. AJNR Am J Neuroradiol. 2018. PMID: 29674411. doi:10.3174/ajnr.A5639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。